276 related articles for article (PubMed ID: 32132149)
21. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
[TBL] [Abstract][Full Text] [Related]
22. Older adults preferences for long-term caregivers in China: a discrete choice experiment.
Leng A; Liu J; Maitland E; Li S; Nicholas S; Ma B; Wang J
Public Health; 2024 Jun; 231():158-165. PubMed ID: 38692091
[TBL] [Abstract][Full Text] [Related]
23. Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Borlenghi E; Cattaneo C; Cerqui E; Archetti S; Bertoli D; Bellotti D; Gramegna D; Soverini G; Oberti M; Schieppati F; Pagani C; Passi A; Sciumé M; Farina M; Carbone C; Crippa C; Dalceggio D; Tucci A; Rossi G
Hematol Oncol; 2020 Dec; 38(5):754-762. PubMed ID: 32950042
[TBL] [Abstract][Full Text] [Related]
24. Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia.
Ciftciler R; Demiroglu H; Buyukasık Y; Aksu S; Goker H
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e205-e212. PubMed ID: 30665867
[TBL] [Abstract][Full Text] [Related]
25. Preferences of patients and clinicians for treatment of Graves' disease: a discrete choice experiment.
van Kinschot CMJ; Soekhai VR; de Bekker-Grob EW; Visser WE; Peeters RP; van Ginhoven TM; van Noord C
Eur J Endocrinol; 2021 May; 184(6):803-812. PubMed ID: 33780350
[TBL] [Abstract][Full Text] [Related]
26. Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis.
Stamuli E; Corry S; Foss P
Int J Technol Assess Health Care; 2023 Apr; 39(1):e21. PubMed ID: 37074007
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
[TBL] [Abstract][Full Text] [Related]
28. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
29. Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.
Geng J; Bao H; Feng Z; Meng J; Yu X; Yu H
BMC Public Health; 2022 Oct; 22(1):1860. PubMed ID: 36199056
[TBL] [Abstract][Full Text] [Related]
30. Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment.
Hazlewood GS; Pokharel G; Deardon R; Marshall DA; Bombardier C; Tomlinson G; Ma C; Seow CH; Panaccione R; Kaplan GG
PLoS One; 2020; 15(1):e0227635. PubMed ID: 31945089
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
Jentzsch M; Bill M; Grimm J; Brauer D; Backhaus D; Goldmann K; Schulz J; Niederwieser D; Platzbecker U; Schwind S
Ann Hematol; 2020 Oct; 99(10):2417-2427. PubMed ID: 32862286
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity in preferences for outcomes of integrated care for persons with multiple chronic diseases: a latent class analysis of a discrete choice experiment.
Hoedemakers M; Karimi M; Jonker M; Tsiachristas A; Rutten-van Mölken M
Qual Life Res; 2022 Sep; 31(9):2775-2789. PubMed ID: 35585287
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614).
Yin J; LaPlant B; Uy GL; Marcucci G; Blum W; Larson RA; Stone RM; Mandrekar SJ
Blood Adv; 2019 Jun; 3(11):1714-1721. PubMed ID: 31171508
[TBL] [Abstract][Full Text] [Related]
34. Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States.
Stein EM; Yang M; Guerin A; Gao W; Galebach P; Xiang CQ; Bhattacharyya S; Bonifacio G; Joseph GJ
Health Qual Life Outcomes; 2018 Sep; 16(1):193. PubMed ID: 30241538
[TBL] [Abstract][Full Text] [Related]
35. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
36. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
[TBL] [Abstract][Full Text] [Related]
37. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
[TBL] [Abstract][Full Text] [Related]
38. Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.
Sun H; Wang H; Shi L; Wang M; Li J; Shi J; Ni M; Hu X; Chen Y
BMJ Open; 2020 Feb; 10(2):e032336. PubMed ID: 32051302
[TBL] [Abstract][Full Text] [Related]
39. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.
Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X
BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447
[TBL] [Abstract][Full Text] [Related]
40. Eliciting patients' preferences for epilepsy diagnostics: a discrete choice experiment.
Wijnen BF; de Kinderen RJ; Colon AJ; Dirksen CD; Essers BA; Hiligsmann M; Leijten FS; Ossenblok PP; Evers SM
Epilepsy Behav; 2014 Feb; 31():102-9. PubMed ID: 24389020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
